Central Valley Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
310
-1
-0.3% -$1.02K 0.1% 139
2026
Q1
$286K Buy
311
+101
+48% +$102K 0.08% 153
2025
Q4
$226K Buy
+210
New +$201K 0.07% 141
2024
Q2
Sell
-314
Closed -$245K 169
2024
Q1
$245K Buy
+314
New +$223K 0.13% 127

Other funds holding LLY

Central Valley Advisors's LLY Position: Q2 2026 in Review

Central Valley Advisors reduced its Eli Lilly (LLY) stake by 0.32% in Q2 2026, selling an estimated $1.02K and leaving 310 shares worth $372K. The position accounts for 0.1% of the portfolio, ranked #139.

Central Valley Advisors first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Central Valley Advisors held 310 shares of Eli Lilly worth $372K as of Q2 2026.
  • Central Valley Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.1% of Central Valley Advisors's portfolio in Q2 2026, its #139 holding.
  • Central Valley Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Central Valley Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.